Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.99
- Piotroski Score 4.00
- Grade Strong Buy
- Symbol (MBINO)
- Company Merchants Bancorp
- Price $25.34
- Changes Percentage (0.25%)
- Change $0.06
- Day Low $25.34
- Day High $25.34
- Year High $25.35
Merchants Bancorp operates as the diversified bank holding company in the United States. The company operates through Multi-family Mortgage Banking, Mortgage Warehousing, and Banking segments. The Multi-family Mortgage Banking segment originates and services government sponsored mortgages for multi-family and healthcare facilities. This segment also offers customized loan products for independent living, assisted living, memory care, and skilled nursing projects; and operates as a syndicator of low-income housing tax credit and debt funds. The Mortgage Warehousing segment funds agency eligible residential loans, including origination, purchase, and sale in the secondary market, as well as commercial loans to non-depository financial institutions. The Banking segment offers a range of financial products and services to consumers and businesses, such as various types of deposit products, as well as multi-family construction and bridge, commercial real estate, commercial and industrial, agricultural, residential mortgage, and consumer loan products. This segment also provides single-family mortgage lending; construction, bridge, and lot financing; first-lien home equity lines of credit; and small business administration lending products and services. Merchants Bancorp was founded in 1990 and is headquartered in Carmel, Indiana.
- Last Earnings 08/15/2024
- Ex-Dividend for 5/16 Dividend 09/13/2024
- Dividend Payable 10/01/2024
- Today N/A
- Next Earnings (Estimated) 01/28/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $4.43
- Trailing P/E Ratio 5.61
- Forward P/E Ratio 5.61
- P/E Growth 5.61
- Net Income $279.23 M
Income Statement
Quarterly
Annual
Latest News of MBINO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
'The Comeback': Where Are the 2004 Boston Red Sox Players Now? Inside Their Lives 20 Years After Breaking the 'Curse of the Bambino'
Samantha Stutsman, a freelance writer and surveillance editor at PEOPLE, discusses Netflix's docuseries on the 2004 Boston Red Sox, highlighting their remarkable journey to breaking the "Curse of the ...
By PEOPLE.com | 2 weeks ago -
Donald Glover cancels his Childish Gambino tour dates after recent surgery - National | Globalnews.ca
Donald Glover, also known as Childish Gambino, has canceled the remaining dates of his tour due to a health issue requiring surgery. Glover expressed his commitment to recovery and gratitude for fans'...
By Global News | 1 month ago -
Donald Glover cancels Childish Gambino tour dates after recent surgery
Musician and actor Donald Glover, known as Childish Gambino, announced the cancellation of his tour due to an undisclosed ailment requiring surgery. The tour was scheduled to hit major cities in North...
By AP NEWS | 1 month ago
